In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests
Despite the expansion of available in-vitro laboratory tests at a rate far exceeding that of dermatological pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up to date o...
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2021-04 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | Journal of the American Academy of Dermatology |
container_volume | |
creator | Nusbaum, Kelsey B Korman, Abraham M Tyler, Kelly Kaffenberger, Jessica Trinidad, John Kaffenberger, Benjamin H |
description | Despite the expansion of available in-vitro laboratory tests at a rate far exceeding that of dermatological pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up to date on the available options, methodologies, and recommendations for when to order one test over another. Understanding inherent strengths and weaknesses of these options is necessary to inform appropriate ordering and proper interpretation of results. The first article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in-vitro laboratory tests used for the workup of undifferentiated patients suspected of having dermatologic autoimmune diseases and provides a general guide to ordering these tests. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33852926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33852926</sourcerecordid><originalsourceid>FETCH-pubmed_primary_338529263</originalsourceid><addsrcrecordid>eNqFzU8LgjAYgPERRNqfrxDvFxCmK6feIouCgg7SVZZOWzgn2-uhb9-lzp2eyw-eCfFDmvIg5gn3yNy5F6U03TA-Ix5jyTZKo9gnl3Mf3BVaA7kSbW8cqspBYyzgU8JV1qoSHeTSaoGmM61ymMFNWIQwg92IRmk99hIK6dAtybQRnZOrbxdkfTwU-1MwjA8t63KwSgv7Ln979hd8AGdLOjo</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests</title><source>Access via ScienceDirect (Elsevier)</source><creator>Nusbaum, Kelsey B ; Korman, Abraham M ; Tyler, Kelly ; Kaffenberger, Jessica ; Trinidad, John ; Kaffenberger, Benjamin H</creator><creatorcontrib>Nusbaum, Kelsey B ; Korman, Abraham M ; Tyler, Kelly ; Kaffenberger, Jessica ; Trinidad, John ; Kaffenberger, Benjamin H</creatorcontrib><description>Despite the expansion of available in-vitro laboratory tests at a rate far exceeding that of dermatological pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up to date on the available options, methodologies, and recommendations for when to order one test over another. Understanding inherent strengths and weaknesses of these options is necessary to inform appropriate ordering and proper interpretation of results. The first article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in-vitro laboratory tests used for the workup of undifferentiated patients suspected of having dermatologic autoimmune diseases and provides a general guide to ordering these tests.</description><identifier>EISSN: 1097-6787</identifier><identifier>PMID: 33852926</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of the American Academy of Dermatology, 2021-04</ispartof><rights>Copyright © 2021. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33852926$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nusbaum, Kelsey B</creatorcontrib><creatorcontrib>Korman, Abraham M</creatorcontrib><creatorcontrib>Tyler, Kelly</creatorcontrib><creatorcontrib>Kaffenberger, Jessica</creatorcontrib><creatorcontrib>Trinidad, John</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H</creatorcontrib><title>In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Despite the expansion of available in-vitro laboratory tests at a rate far exceeding that of dermatological pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up to date on the available options, methodologies, and recommendations for when to order one test over another. Understanding inherent strengths and weaknesses of these options is necessary to inform appropriate ordering and proper interpretation of results. The first article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in-vitro laboratory tests used for the workup of undifferentiated patients suspected of having dermatologic autoimmune diseases and provides a general guide to ordering these tests.</description><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFzU8LgjAYgPERRNqfrxDvFxCmK6feIouCgg7SVZZOWzgn2-uhb9-lzp2eyw-eCfFDmvIg5gn3yNy5F6U03TA-Ix5jyTZKo9gnl3Mf3BVaA7kSbW8cqspBYyzgU8JV1qoSHeTSaoGmM61ymMFNWIQwg92IRmk99hIK6dAtybQRnZOrbxdkfTwU-1MwjA8t63KwSgv7Ln979hd8AGdLOjo</recordid><startdate>20210411</startdate><enddate>20210411</enddate><creator>Nusbaum, Kelsey B</creator><creator>Korman, Abraham M</creator><creator>Tyler, Kelly</creator><creator>Kaffenberger, Jessica</creator><creator>Trinidad, John</creator><creator>Kaffenberger, Benjamin H</creator><scope>NPM</scope></search><sort><creationdate>20210411</creationdate><title>In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests</title><author>Nusbaum, Kelsey B ; Korman, Abraham M ; Tyler, Kelly ; Kaffenberger, Jessica ; Trinidad, John ; Kaffenberger, Benjamin H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_338529263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nusbaum, Kelsey B</creatorcontrib><creatorcontrib>Korman, Abraham M</creatorcontrib><creatorcontrib>Tyler, Kelly</creatorcontrib><creatorcontrib>Kaffenberger, Jessica</creatorcontrib><creatorcontrib>Trinidad, John</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H</creatorcontrib><collection>PubMed</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nusbaum, Kelsey B</au><au>Korman, Abraham M</au><au>Tyler, Kelly</au><au>Kaffenberger, Jessica</au><au>Trinidad, John</au><au>Kaffenberger, Benjamin H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2021-04-11</date><risdate>2021</risdate><eissn>1097-6787</eissn><abstract>Despite the expansion of available in-vitro laboratory tests at a rate far exceeding that of dermatological pharmaceuticals, the existing literature is dominated by discussion of the latter. With the advent of numerous new tests, it can be difficult for practicing dermatologists to stay up to date on the available options, methodologies, and recommendations for when to order one test over another. Understanding inherent strengths and weaknesses of these options is necessary to inform appropriate ordering and proper interpretation of results. The first article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in-vitro laboratory tests used for the workup of undifferentiated patients suspected of having dermatologic autoimmune diseases and provides a general guide to ordering these tests.</abstract><cop>United States</cop><pmid>33852926</pmid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1097-6787 |
ispartof | Journal of the American Academy of Dermatology, 2021-04 |
issn | 1097-6787 |
language | eng |
recordid | cdi_pubmed_primary_33852926 |
source | Access via ScienceDirect (Elsevier) |
title | In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A50%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In-Vitro%20Diagnostics%20for%20the%20Medical%20Dermatologist:%20Part%201:%20Autoimmune%20Tests&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Nusbaum,%20Kelsey%20B&rft.date=2021-04-11&rft.eissn=1097-6787&rft_id=info:doi/&rft_dat=%3Cpubmed%3E33852926%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33852926&rfr_iscdi=true |